Challenges in Rare Diseases Treatment

There are around 7,000 rare diseases, which from a regulatory outlook are defined as those diseases where there are less than 200,000 patients in the US or that affect no more than five in 10,000 of the general population in the EU. Orphan drugs are medicinal products envisioned for diagnosis, prevention, and treatment of life-threatening rare diseases. They are "orphans" because the pharmaceutical industry has little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.

    Related Conference of Challenges in Rare Diseases Treatment

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic
    June 29-30, 2026

    7th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 25-26, 2026

    18th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Challenges in Rare Diseases Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in